Austedo XR 30 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q7Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,455
Award facts
- Contract value 100% obligated
- $23,454.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,454.95 to AmerisourceBergen Drug Corp for the supply of AUSTEDO XR 30 mg tablets (30-count bottles). This firm fixed-price, non-set-aside contract was awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.999 billion through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated substantial capability in fulfilling federal medical procurement needs through competitive awards. The company's extensive portfolio with the DLA encompasses delivery of a diverse range of pharmaceutical products across multiple therapeutic domains, including neurological treatments, diabetes medications, pain management pharmaceuticals, and specialized medical supplies. The firm fixed-price structure and expedited delivery timeline reflect the critical nature of pharmaceutical supply chain support to military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9Q7Y?
SPE2DR26F9Q7Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F9Q7Y worth?
The government has obligated $23,455 on SPE2DR26F9Q7Y.
Is contract SPE2DR26F9Q7Y an order under another contract?
Yes. SPE2DR26F9Q7Y is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9Q7Y competed?
The extent of competition for SPE2DR26F9Q7Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award